Assessment of the prognostic and discriminating value of the novel bioscore system for breast cancer; a SEER database analysis
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology
Link
http://link.springer.com/article/10.1007/s10549-017-4244-2/fulltext.html
Reference16 articles.
1. http://globocan.iarc.fr . Last accessed on 27/11/2016
2. Abdoli G, Bottai M, Sandelin K, Moradi T (2017) Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in Sweden. Breast (Edinburgh, Scotland) 31:57–65
3. Jackisch C, Lammers P, Jacobs I (2017) Evolving landscape of human epidermal growth factor receptor 2-positive breast cancer treatment and the future of biosimilars. Breast (Edinburgh, Scotland) 32:199–216
4. Amin MB, Greene FL, Greene FL, Edge SB, Edge SB, Compton CC, Gershenwald JE, Brookland RK et al (2017) The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin 67(2):93–99
5. Bagaria SP, Ray PS, Sim MS, Ye X, Shamonki JM, Cui X et al (2014) Personalizing breast cancer staging by the inclusion of ER, PR, and HER2. JAMA surgery 149(2):125–129
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Relative Burden of Cancer and Noncancer Mortality Among Long-Term Survivors of Breast, Prostate, and Colorectal Cancer in the US;JAMA Network Open;2023-07-12
2. Combination of Anatomical and Biological Factors to Predict Disease-Free Survival in Breast Cancer;JCO Global Oncology;2023-03
3. Expanding the Staging Criteria for T1-2N0 Hormone-Receptor Positive Breast Cancer Patients Enrolled in TAILORx;Annals of Surgical Oncology;2022-07-27
4. Molecular Subtypes, Metastatic Pattern and Patient Age in Breast Cancer: An Analysis of Italian Network of Cancer Registries (AIRTUM) Data;Journal of Clinical Medicine;2021-12-14
5. Expanding Criteria for Prognostic Stage IA in Hormone Receptor–Positive Breast Cancer;JNCI: Journal of the National Cancer Institute;2021-05-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3